Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension
- 1 November 2002
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 74 (10) , 1395-1400
- https://doi.org/10.1097/00007890-200211270-00009
Abstract
Most heart transplant (HTx) recipients develop hypertension, characterized by increased peripheral vascular tone and endothelial dysfunction. Reduced levels of nitric oxide (NO) have been found in essential hypertension, and herein we investigated the possible role of altered concentrations of NO in posttransplant hypertension. Plasma levels of the NO-derived end products NO2(-) + NO3(-), the endogenous inhibitor of NO synthase asymmetric dimethylarginine (ADMA), and the inflammatory cytokine tumor necrosis factor (TNF)-alpha were examined in 65 stable hypertensive long-term (6 years [range 1-13]) survivors of HTx. HTx recipients were compared with 39 individuals with essential hypertension and 25 normotensive controls. RESULTS Hypertensive HTx recipients had raised NO2(-) + NO3(-) levels in plasma, positively correlated with 24-hour mean blood pressure (BP). In contrast, individuals with essential hypertension had decreased NO2(-) + NO3(-) concentration comparing controls, inversely correlated with 24-hour mean BP. Moreover, although TNF-alpha levels were significantly raised in HTx recipients compared with both healthy controls and individuals with essential hypertension, it was positively correlated to 24-hour BP and NO2(-) + NO3(-). Although only a slight increase was found in essential hypertension, no correlations were found in these nontransplant individuals. Finally, although asymmetric dimethylarginine (ADMA) tended to be raised in essential hypertension, this endogenous nitric oxide synthase (NOS) inhibitor was significantly decreased in HTx recipients compared with normotensive controls. Our findings suggest that different mechanisms may be operating in the pathogenesis of posttransplant compared with essential hypertension, with persistent inflammation, raised NO2(-) + NO3(-), and decreased ADMA levels characterizing the former group.Keywords
This publication has 34 references indexed in Scilit:
- Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipientsEuropean Heart Journal, 2001
- Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-αPublished by Oxford University Press (OUP) ,1999
- Manifestation of Oxidative Stress in the Pathogenesis of Arterial Hypertension in ISIAH RatsBiochemical and Biophysical Research Communications, 1999
- Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: Different stimuli for release before and after heart transplantation?American Heart Journal, 1999
- Cyclosporin A Increases Nitric Oxide Activity In VivoHypertension, 1997
- Serum Levels of Tumor Necrosis Factor- (TNF ) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic ParametersThe Journal of Infectious Diseases, 1994
- Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studiesThe American Journal of Cardiology, 1991
- Cardiac transplant hypertensionThe American Journal of Cardiology, 1990
- EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MANThe Lancet, 1989
- Effect of insulinopenia and adrenal hormone deficiency on acute potassium toleranceKidney International, 1980